These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17617518)

  • 21. The role of secondary cytoreductive surgery for recurrent ovarian cancer.
    Güngör M; Ortaç F; Arvas M; Kösebay D; Sönmezer M; Köse K
    Gynecol Oncol; 2005 Apr; 97(1):74-9. PubMed ID: 15790440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of ovarian germ cell tumors.
    Gershenson DM
    J Clin Oncol; 2007 Jul; 25(20):2938-43. PubMed ID: 17617525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.
    Reichman TW; Cracchiolo B; Sama J; Bryan M; Harrison J; Pliner L; Harrison LE
    J Surg Oncol; 2005 May; 90(2):51-6; discussion 56-8. PubMed ID: 15844187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical therapy of ovarian carcinoma].
    Sevelda P
    Wien Med Wochenschr; 1996; 146(1-2):18-22. PubMed ID: 8835491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of borderline ovarian neoplasms.
    Cadron I; Leunen K; Van Gorp T; Amant F; Neven P; Vergote I
    J Clin Oncol; 2007 Jul; 25(20):2928-37. PubMed ID: 17617524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of ovarian stromal cell tumors.
    Colombo N; Parma G; Zanagnolo V; Insinga A
    J Clin Oncol; 2007 Jul; 25(20):2944-51. PubMed ID: 17617526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgery of germ cell tumours of the ovary.
    Schwartz PE
    Forum (Genova); 2000; 10(4):355-65. PubMed ID: 11535985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].
    Sato K; Horiguchi M; Kimura M; So E; Kojima T; Tamuna M; Shima Y; Numaguchi M; Uno K; Maru H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1070-7. PubMed ID: 2730012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer.
    Ushijima K; Ota S; Komai K; Matsuo G; Motoshima S; Honda S; Tomonari R; Sugiyama T; Kamura T
    Int Surg; 2002; 87(3):185-90. PubMed ID: 12403096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ovarian cancer--diagnostic dilemmas and unusual therapeutic response].
    Păun I; Mogoş D; Păun M; Vasile I; Florescu M; Tenovici M; Ionescu M; Coajă F; Dumitrelea D; Teodorescu M; Picu M; Cotârţă I; Muşat S
    Chirurgia (Bucur); 2004; 99(3):137-42. PubMed ID: 15455696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer.
    Dowdy SC; Metzinger DS; Gebhart JB; Srivatsa P; Haddock MG; Suman VJ; Podratz KC
    Gynecol Oncol; 2005 Feb; 96(2):389-94. PubMed ID: 15661226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
    Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
    Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach.
    Burton E; Chase D; Yamamoto M; de Guzman J; Imagawa D; Berman ML
    Gynecol Oncol; 2011 Jan; 120(1):29-32. PubMed ID: 21055797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-look surgery in the management of epithelial ovarian carcinoma.
    Podratz KC; Cliby WA
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S128-33. PubMed ID: 7835796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.